Philip Vanek
Technik-/Wissenschafts-/F&E-Leiter bei Gamma Biosciences
Aktive Positionen von Philip Vanek
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Centre For Commercialization of Regenerative Medicine
 Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | 16.07.2015 | - |
Gamma Biosciences
 Gamma Biosciences Packaged SoftwareTechnology Services Gamma Biosciences operates as a life sciences tools platform. It focuses on next-generation bioprocessing and technologies for the production of advanced therapies, such as gene and cell-based therapies. The company was founded in 2019 and is headquartered in Menlo Park, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2020 | - |
Karriereverlauf von Philip Vanek
Statistik
International
| Kanada | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 2 |
| Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Centre For Commercialization of Regenerative Medicine
Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Health Technology |
Gamma Biosciences
Gamma Biosciences Packaged SoftwareTechnology Services Gamma Biosciences operates as a life sciences tools platform. It focuses on next-generation bioprocessing and technologies for the production of advanced therapies, such as gene and cell-based therapies. The company was founded in 2019 and is headquartered in Menlo Park, CA. | Technology Services |
- Börse
- Insiders
- Philip Vanek
- Erfahrung
